Related Experiment Video
Updated: Jun 22, 2025

10:46
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
3.6K
Empowering Exosomes with Aptamers for Precision Theranostics.
Liyan Zheng1,2, Jin Li1, Yingying Li2
1Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China.
Small Methods
|July 5, 2024
Summary
Aptamers enhance exosomes for precise theranostics. This review explores aptamer-based exosome detection for disease diagnosis and aptamer-functionalized exosomes for targeted therapeutics, addressing current challenges and opportunities.
Area of Science:
- Biotechnology and Nanomedicine
- Molecular Biology and Diagnostics
Background:
- Exosomes are vital cell-to-cell communicators and promising theranostic agents for diagnosis and drug delivery.
- Clinical use of exosomes is limited by unspecific detection and poor targeting.
- Aptamers offer high affinity and easy modification for molecular recognition.
Purpose of the Study:
- To review the use of aptamers in empowering exosomes for precision theranostics.
- To discuss advancements in aptamer-based exosome detection for disease diagnostics.
- To highlight applications of aptamer-functionalized exosomes in targeted therapeutics.
Main Methods:
- Review of current literature on aptamer-exosome conjugates for theranostics.
- Discussion of aptamer incorporation for specific exosome detection platforms.
- Analysis of aptamer functionalization on exosomes for targeted delivery.
Main Results:
- Aptamers improve the specificity and targeting of exosomes for theranostic applications.
- Aptamer-based detection enhances exosome utility in liquid biopsy and disease diagnostics.
- Functionalized exosomes show potential for targeted drug delivery and therapeutic interventions.
Conclusions:
- Aptamer integration is key to overcoming exosome limitations in theranostics.
- Further research into aptamer-exosome systems offers significant opportunities for precision medicine.
- Addressing current challenges will accelerate the clinical translation of these advanced theranostic tools.

